Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and risk factors of small airway dysfunction among rural residents in Western China: a real-world cross-sectional study.

NPJ primary care respiratory medicine·2026
Same author

Hepatic congestion and metabolic acidosis caused by aortic dissection with massive pericardial effusion.

Innovation (Cambridge (Mass.))·2026
Same author

A Humanized Knock-in Mouse Model of the PSEN1 V97L Mutation from a Major Chinese Alzheimer's Disease Pedigree Reveals Early Neuroinflammation.

Neuroscience bulletin·2026
Same author

Mitral valve surgery combined with on-pump coronary artery bypass grafting (CABG) versus off-pump or on-pump beating heart CABG: a retrospective cohort study.

Journal of thoracic disease·2026
Same author

SnRK2 and MLKs orchestrate FREE1 nuclear retention through phosphorylation to regulate ABA signaling in Arabidopsis.

Plant science : an international journal of experimental plant biology·2026
Same author

Differential modal gain optimization for weakly-coupled few-mode multi-core erbium-doped fiber amplifiers.

Optics express·2026

Related Experiment Video

Updated: Feb 23, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

3.4K

Targeting EIF4F complex in non-small cell lung cancer cells.

Lu Dai1,2,3, Zhen Lin4, Yueyu Cao3

  • 1Department of Genetics, Louisiana State University Health Sciences Center, Louisiana Cancer Research Center, New Orleans, LA 70112, USA.

Oncotarget
|September 15, 2017
PubMed
Summary

The EIF4F complex impacts non-small cell lung cancer (NSCLC) progression. This review explores its role and potential as a therapeutic target for NSCLC, offering new treatment avenues.

Keywords:
EIF4AEIF4EEIF4FEIF4Geukaryotic initiation factors

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.7K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

460

Related Experiment Videos

Last Updated: Feb 23, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

3.4K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.7K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

460

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide, with limited treatment efficacy for many patients.
  • Conventional therapies offer poor outcomes, and while targeted therapy and immunotherapy show promise, patient prognosis remains unsatisfactory.
  • The EIF4F complex's role in cancer progression is recognized, but its specific function and therapeutic potential in NSCLC are largely uninvestigated.

Purpose of the Study:

  • To review current knowledge on the EIF4F complex's involvement in NSCLC progression.
  • To explore the therapeutic potential of targeting the EIF4F complex in NSCLC treatment.
  • To identify knowledge gaps and suggest future research directions in this area.

Main Methods:

  • Literature review of recent findings on EIF4F complex in NSCLC.
  • Analysis of EIF4F complex's role in cancer progression mechanisms.
  • Evaluation of EIF4F complex as a target for NSCLC therapies.

Main Results:

  • The EIF4F complex plays a significant role in the progression of NSCLC.
  • Evidence suggests that targeting the EIF4F complex could be a viable therapeutic strategy for NSCLC.
  • Current understanding of the EIF4F complex's precise functions and therapeutic implications in NSCLC is limited.

Conclusions:

  • The EIF4F complex is a critical factor in NSCLC progression and presents a promising therapeutic target.
  • Further research is needed to fully elucidate the EIF4F complex's mechanisms in NSCLC and optimize targeted therapies.
  • Understanding the EIF4F complex offers potential for improved treatment strategies and patient outcomes in NSCLC.